Table of contents
Volume 85, Issue 9
Published online 30 October 2001 (1233-1419)
Review
Radiation induced CNS toxicity – molecular and cellular mechanisms FREE
C Belka, W Budach, R D Kortmann and M Bamberg
Br J Cancer 85: 1233-1239; doi:10.1054/bjoc.2001.2100
Regular Articles
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study FREE
P H Cottu, J M Extra, M Espie, J P Marolleau, A de Roquancourt, J Makke, J M Miclea, V Laurence, D Mayeur, F Lerebours, C Cuvier and M Marty
Br J Cancer 85: 1240-1246; doi:10.1054/bjoc.2001.2069
Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere) FREE
G-S Wang, K-Y Yang and R-P Perng
Br J Cancer 85: 1247-1250; doi:10.1054/bjoc.2001.2071
Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice FREE
C Bouchardy, P-E Queneau, G Fioretta, M Usel, M Zellweger, I Neyroud, L Raymond, C de Wolf and A P Sappino
Br J Cancer 85: 1251-1257; doi:10.1054/bjoc.2001.2035
Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer FREE
I Chau, A Webb, D Cunningham, M Hill, J S Waters, A Norman and A Massey
Br J Cancer 85: 1258-1264; doi:10.1054/bjoc.2001.2036
Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients FREE
K Nordin, J Steel, K Hoffman and B Glimelius
Br J Cancer 85: 1265-1272; doi:10.1054/bjoc.2001.2046
Promoting patient participation and shortening cancer consultations: a randomised trial FREE
R F Brown, P N Butow, S M Dunn and M H N Tattersall
Br J Cancer 85: 1273-1279; doi:10.1054/bjoc.2001.2073
First do no harm: extending the debate on the provision of preventive tamoxifen FREE
B P Will, K M Nobrega, J-M Berthelot, W Flanagan, M C Wolfson, D M Logan and W K Evans
Br J Cancer 85: 1280-1288; doi:10.1054/bjoc.2001.2125
Routine breast screening for women aged 65–69: results from evaluation of the demonstration sites FREE
S M Moss, J Brown, L Garvican, D A Coleman, L E Johns, R G Blanks, G Rubin, J Oswald, A Page, A Evans, R Wilson, L Lee, J Liston, L Sturdy, G Sutton, G Wardman, J Patnick and R Winder
Br J Cancer 85: 1289-1294; doi:10.1054/bjoc.2001.2047
Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period FREE
C Carroll-Pankhurst, E A Engels, H D Strickler, J J Goedert, J Wagner and E A Mortimer Jr
Br J Cancer 85: 1295-1297; doi:10.1054/bjoc.2001.2065
Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma FREE
E A Engels, P S Rosenberg, M Frisch and J J Goedert
Br J Cancer 85: 1298-1303; doi:10.1054/bjoc.2001.2052
Combined risk factors for melanoma in a Mediterranean population FREE
M T Landi, A Baccarelli, D Calista, A Pesatori, T Fears, M A Tucker and G Landi
Br J Cancer 85: 1304-1310; doi:10.1054/bjoc.2001.2029
Physical activity and risk of cancer in middle-aged men FREE
S G Wannamethee, A G Shaper and M Walker
Br J Cancer 85: 1311-1316; doi:10.1054/bjoc.2001.2096
Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma FREE
W Ye, W-H Chow, J Lagergren, P Boffetta, G Boman, H-O Adami and O Nyrén
Br J Cancer 85: 1317-1321; doi:10.1054/bjoc.2001.2094
A minimum estimate for the incidence of gastric cancer in Eastern Kenya FREE
G McFarlane, D Forman, F Sitas and G Lachlan
Br J Cancer 85: 1322-1325; doi:10.1054/bjoc.2001.1994
An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case–control study FREE
H Tsukada, Y Kurita, A Yokoyama, S Wakai, T Nakayama, M Sagawa and H Misawa
Br J Cancer 85: 1326-1331; doi:10.1054/bjoc.2001.2060
Short Communication
Cancer incidence in the Falkland Islands FREE
A J Swerdlow, B Elsby and Z Qiao
Br J Cancer 85: 1332-1334; doi:10.1054/bjoc.2001.2099
Regular Articles
Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects FREE
S Liu, R Semenciw, A-M Ugnat and Y Mao
Br J Cancer 85: 1335-1339; doi:10.1054/bjoc.2001.2061
Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes FREE
R A Wascher, P J Bostick, K T Huynh, R Turner, K Qi, A E Giuliano and D S B Hoon
Br J Cancer 85: 1340-1346; doi:10.1054/bjoc.2001.2079
Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients FREE
G H de Bock, R A E M Tollenaar, H Papelard, C J Cornelisse, P Devilee and M J van de Vijver
Br J Cancer 85: 1347-1350; doi:10.1054/bjoc.2001.2103
Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas FREE
J M Arnold, M Cummings, D Purdie and G Chenevix-Trench
Br J Cancer 85: 1351-1358; doi:10.1054/bjoc.2001.2075
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2 FREE
M Schuyer, M E L van der Burg, S C Henzen-Logmans, J H Fieret, J G M Klijn, M P Look, J A Foekens, G Stoter and E M J J Berns
Br J Cancer 85: 1359-1367; doi:10.1054/bjoc.2001.2101
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases FREE
A Figer, R Shtoyerman-Chen, A Tamir, R Geva, L Irmin, D Flex, L Theodor, A Sulkes, S Sadetzki, S Bar-Meir and E Friedman
Br J Cancer 85: 1368-1371; doi:10.1054/bjoc.2001.2093
Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization FREE
M J J G Stassar, G Devitt, M Brosius, L Rinnab, J Prang, T Schradin, J Simon, S Petersen, A Kopp-Schneider and M Zöller
Br J Cancer 85: 1372-1382; doi:10.1054/bjoc.2001.2074
No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours FREE
S Jefferies, S M Edwards, R A Hamoudi, R A'Hern, W Foulkes, D Goldgar, M. P. T. CollaboratorsR Eeles
Br J Cancer 85: 1383-1386; doi:10.1054/bjoc.2001.2068
Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor FREE
I Vande Broek, K Vanderkerken, C De Greef, K Asosingh, N Straetmans, B Van Camp and I Van Riet
Br J Cancer 85: 1387-1395; doi:10.1054/bjoc.2001.2078
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma FREE
E Rivera, O Arrieta, P Guevara, A Duarte-Rojo and J Sotelo
Br J Cancer 85: 1396-1399; doi:10.1054/bjoc.2001.2102
Short Communication
New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells FREE
M M Alonso, I Encío, V Martínez-Merino, M Gil and M Migliaccio
Br J Cancer 85: 1400-1402; doi:10.1054/bjoc.2001.2083
Regular Articles
Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells FREE
X M Liu, L G Wang, W Kreis, D R Budman and L M Adams
Br J Cancer 85: 1403-1411; doi:10.1054/bjoc.2001.2107
Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors FREE
N Cattan, N Rochet, C Mazeau, E Zanghellini, B Mari, C Chauzy, H Stora de Novion, J Amiel, J-L Lagrange, B Rossi and J Gioanni
Br J Cancer 85: 1412-1417; doi:10.1054/bjoc.2001.2105
Letter to the Editor
The apolipoprotein E 
4 allele is no risk factor for prostate cancer in the Norwegian population FREE
N Wessel, K Liestøl, J Mæhlen and S H Brorson
Br J Cancer 85: 1418; doi:10.1054/bjoc.2001.2098
Calendar
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
